Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 3
1962 1
1964 5
1965 1
1967 2
1968 4
1969 3
1970 1
1972 1
1973 1
1974 2
1975 2
1976 2
1977 3
1978 5
1979 7
1980 5
1981 1
1982 4
1983 5
1984 5
1985 2
1986 3
1987 4
1989 12
1990 4
1991 7
1992 6
1993 7
1994 5
1995 9
1996 7
1997 7
1998 8
1999 3
2000 8
2001 9
2002 15
2003 7
2004 8
2005 11
2006 15
2007 12
2008 26
2009 15
2010 16
2011 15
2012 24
2013 34
2014 21
2015 22
2016 34
2017 32
2018 37
2019 36
2020 42
2021 42
2022 44
2023 32
2024 37
2025 45
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

709 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean shin do t[au] (9 results)?
Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease.
Sawamoto N, Doi D, Nakanishi E, Sawamura M, Kikuchi T, Yamakado H, Taruno Y, Shima A, Fushimi Y, Okada T, Kikuchi T, Morizane A, Hiramatsu S, Anazawa T, Shindo T, Ueno K, Morita S, Arakawa Y, Nakamoto Y, Miyamoto S, Takahashi R, Takahashi J. Sawamoto N, et al. Among authors: shindo t. Nature. 2025 May;641(8064):971-977. doi: 10.1038/s41586-025-08700-0. Epub 2025 Apr 16. Nature. 2025. PMID: 40240591 Free PMC article. Clinical Trial.
Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson's disease.
Morizane A, Yamasaki E, Shindo T, Anazawa T, Sawamoto N, Shima A, Yamakado H, Nakanishi E, Sawamura M, Taruno Y, Doi D, Kikuchi T, Kawasaki Y, Saito MK, Kikuchi T, Arakawa Y, Miyamoto S, Nakamoto Y, Takahashi R, Takahashi J. Morizane A, et al. Among authors: shindo t. Cell Stem Cell. 2025 Sep 4;32(9):1346-1355.e3. doi: 10.1016/j.stem.2025.07.012. Epub 2025 Aug 19. Cell Stem Cell. 2025. PMID: 40834856 Free article. Clinical Trial.
Cross-organ hierarchy of HLA molecular mismatches in donor-specific antibody development in solid organ transplantations.
Hirata M, Tsukita K, Shindo T, Yagi S, Ito T, Tanaka S, Fujimoto R, Kayawake H, Nakamura K, Fujiyama N, Saito M, Yurugi K, Hishida R, Kato A, Kawaguchi A, Habuchi T, Kobayashi T, Date H, Hatano E. Hirata M, et al. Among authors: shindo t. Cell Rep Med. 2025 Jun 17;6(6):102153. doi: 10.1016/j.xcrm.2025.102153. Epub 2025 May 30. Cell Rep Med. 2025. PMID: 40449481 Free PMC article.
Adenovirus-Associated Uveitis with Necrotizing Retinitis.
Sugita S, Usui Y, Watanabe H, Panto L, Iida M, Suginoshita K, Koyanagi KO, Nishida A, Kurimoto Y, Takahashi M, Shindo T, Nishioka H, Takano M, Kezuka T, Goto H, Kitaichi N. Sugita S, et al. Among authors: shindo t. Ophthalmology. 2023 Apr;130(4):443-445. doi: 10.1016/j.ophtha.2022.12.020. Epub 2022 Dec 23. Ophthalmology. 2023. PMID: 36572255 No abstract available.
Tirabrutinib for CNS relapsed primary vitreoretinal lymphoma.
Yoshida N, Ureshino H, Hiyama T, Harada Y, Nakatani S, Chishaki R, Edahiro T, Yoshida T, Shindo T, Ichinohe T. Yoshida N, et al. Among authors: shindo t. Ann Hematol. 2025 Mar;104(3):2073-2074. doi: 10.1007/s00277-025-06284-3. Epub 2025 Mar 4. Ann Hematol. 2025. PMID: 40032699 Free PMC article. No abstract available.
709 results